Obstetric innovation

Kogutt, Benjamin K.; Satin, Andrew J.

doi:10.1016/j.ajog.2020.05.047

Cited by 3 publications

(6 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Adicionalmente, a presença ou ausência de comorbidade é um importante indicador de saúde, haja vista que possuir quaisquer comorbidades associadas à infecção se relaciona com maior risco para evolução para quadros graves 33,13 . Aponta-se ainda a probabilidade aumentada de gestantes hipertensas e diabéticas infectadas serem submetidas à cesariana emergencial ou parto prematuro 32 , o que também eleva o risco de óbito materno e neonatal 34,13 . No contexto pandêmico, encontraram-se dados semelhantes aos dessa série de casos, com distribuição quase igualitária entre gestantes com e sem comorbidade 34 .…”

Section: Discussionunclassified

Desfechos obstétricos adversos durante a COVID-19: uma série de casos retrospectiva

Resende,

Souza,

Freitas

et al. 2024

Rev. enferm. UERJ

View full text Add to dashboard Cite

Objetivo: analisar as características e os desfechos obstétricos adversos em gestantes/puérperas infectadas pelo SARS-CoV-2 em serviço de referência. Método: série de casos retrospectiva entre gestantes com Covid-19 em um hospital universitário em Minas Gerais, Brasil, atendidas no serviço de 2020 a 2021, coletados em abril de 2022, empregando-se estatística descritiva para análise dos dados através do Statistical Package for the Social Science. Resultados: incluídas 26 gestantes, em sua maioria brancas, que tiveram como principais desfechos obstétricos adversos a internação em UTI (43,5%), parto prematuro (34,6%), dado reestratificado de semanas para dias para investigar o encurtamento da gestação, onde constatou-se média de 38,6 dias potenciais de gravidez perdidos dos 280 dias ideais, e ainda 15,4% evoluíram para óbito materno. Conclusão: o estudo proporcionou evidenciar a necessidade de vigilância e atenção às gestantes com foco nos principais desfechos adversos, podendo-se intervir em tempo oportuno para diminuir adversidades.

show abstract

Section: Discussionunclassified

Desfechos obstétricos adversos durante a COVID-19: uma série de casos retrospectiva

Resende,

Souza,

Freitas

et al. 2024

Rev. enferm. UERJ

View full text Add to dashboard Cite

show abstract

“…Pregnancies during the pandemic have also raised additional concerns. A study conducted in New York revealed that 15% of pregnant women with Covid-19 died after receiving treatment at a hospital (Kogutt & Satin, 2020). Overall, it is evident that the United States has a maternal mortality problem, and this issue is being further highlighted with the increased attention to social determinants of health, as well as the impact of the Covid-19 pandemic.…”

Section: Literature Reviewmentioning

confidence: 99%

Birth Experiences of Black Women and Impact of Mother's Perceptions, Control, and Responsive Care

Lash,

Hernandez

2023

J Stud Res

View full text Add to dashboard Cite

Maternal mortality in America, especially among African American women, has become an increasingly popular topic over the past few years. This project uses a phenomenological approach to analyze the birthing experiences of African American women. The personal narratives of African American mothers provide a unique perspective surrounding the American birthing crisis. They can play a crucial role alongside statistical analysis to provide a much-needed solution. Lack of control, feelings of disempowerment, and racial discrimination were common themes among the ten narratives analyzed. Employee racial competency training and diversifying healthcare teams could be a step in the right direction regarding the current maternal mortality crisis in America. However, further research with a larger sample size can provide additional insight into common themes in the birthing experience of African American women.

show abstract

“…Recurrence is more common with long‐RP types of tachycardias. Sometimes fetal bundle branch block is noted immediately after delivery 41–43 . This is most common with flecainide, especially when its treatments are overlapped with sotalol or amiodarone.…”

Section: Treatment Of Fetal Tachyarrhythmiamentioning

confidence: 99%

“…Finally, as outlined by Kogutt and Satin 41 in a recent article, research innovations in obstetrics lag far behind those of other medical disciplines with regard to funding, industry investment, patents, and companies producing products. This could be addressed by establishing a fetal drug and device consortium, funded by the National Institutes of Health or FDA to promote research and the translation of promising device technologies and drugs, including future gene therapies, for the human fetus in need of treatment.…”

Section: Treatment Of Fetal Tachyarrhythmiamentioning

confidence: 99%

See 1 more Smart Citation

Fetal Arrhythmia Diagnosis and Pharmacologic Management

Strasburger

Eckstein

Butler

et al. 2022

The Journal of Clinical Pharma

View full text Add to dashboard Cite

One of the most successful achievements of fetal intervention is the pharmacologic management of fetal arrhythmias. This management usually takes place during the second or third trimester. While most arrhythmias in the fetus are benign, both tachy-and bradyarrhythmias can lead to fetal hydrops or cardiac dysfunction and require treatment under certain conditions. This review will highlight precise diagnosis by fetal echocardiography and magnetocardiography, the 2 primary means of diagnosing fetuses with arrhythmia. Additionally, transient or hidden arrhythmias such as bundle branch block, QT prolongation, and torsades de pointes, which can lead to cardiomyopathy and sudden unexplained death in the fetus, may also need pharmacologic treatment. The review will address the types of drug therapies; current knowledge of drug usage, efficacy, and precautions; and the transition to neonatal treatments when indicated. Finally, we will highlight new assessments, including the role of the nurse in the care of fetal arrhythmias. The prognosis for the human fetus with arrhythmias continues to improve as we expand our ability to provide intensive care unit-like monitoring, to better understand drug treatments, to optimize subsequent pregnancy monitoring, to effectively predict timing for delivery, and to follow up these conditions into the neonatal period and into childhood. Coordinated initiatives that facilitate clinical fetal research are needed to address gaps in knowledge and to facilitate fetal drug and device development.

show abstract

Obstetric innovation

Cited by 3 publications

References 1 publication

Desfechos obstétricos adversos durante a COVID-19: uma série de casos retrospectiva

Desfechos obstétricos adversos durante a COVID-19: uma série de casos retrospectiva

Birth Experiences of Black Women and Impact of Mother's Perceptions, Control, and Responsive Care

Fetal Arrhythmia Diagnosis and Pharmacologic Management

Contact Info

Product

Resources

About